跳至主要内容
临床试验/IRCT20200921048793N1
IRCT20200921048793N1已完成3 期

Effect of ingestion of Iranian native multi-strain probiotic Supplement on inflammatory and oxidative stress factors in Parkinson's disease patients

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Age over 18 and under 80
  • Diagnosis of idiopathic Parkinson's disease based on UK PD Society Brain Bank criteria
  • Using l-dopa or dopaminergic agonist

排除标准

  • Use of systemic antibiotics, antifungals, antivirals or antiparasitics (intravenous, intramuscular, or oral)
  • Use of commercial probiotics: includes tablets, capsules.
  • Major surgery of the GI tract, with the exception of cholecystectomy and appendectomy, in the past five years
  • History of active uncontrolled gastrointestinal disorders or diseases including: inflammatory bowel disease (IBD) including ulcerative colitis (mild-moderate-severe), Crohn's disease (mild-moderate-severe), or indeterminate colitis
  • Infectious gastroenteritis, colitis or gastritis, persistent or chronic diarrhea of unknown etiology, Clostridium difficile infection (recurrent) or Helicobacter pylori infection (untreated)
  • Age over 80

研究者

相似试验